Anthony Marciano of Seelos Therapeutics (NASDAQ: SEEL) will give an overview on how the FDA approval process works for prescription drugs. He will discuss his company and their plans to develop treatments in indications such as Depression, Parkinson’s Disease and rare “Orphan Diseases.” Most notably will be an in-depth discussion of the Global Suicide Epidemic, Seelos’ program (SLS-002) using Intranasal Ketamine, and plans to run clinical trials to study its effect in “Suicidality” initially in Post-Traumatic Stress Disorder “PTSD.”
Angelo Spilios cooked an amazing BBQ meal for us as he’s done many times in the past. Thanks to Donato Vaccaro, Tom Cascione, and others who volunteered their time and effort to make this evening possible.